CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Luye Pharma Group Limited Company Snapshot
Luye Pharma Group Limited operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Luye Pharma Group Limited with three other pharmaceutical manufacturers in Asia: Shanxi Zhendong Pharmaceutical Co Ltd of China (2017 sales of 3.73 billion Chinese Renmimbi [US$544.22 million] of which 101% was Medicine Manufacture and Sale), ChangChun High New Technology Industries of China (4.04 billion Chinese Renmimbi [US$589.11 million] of which 85% was Medication), and JW Holdings Corporation which is based in South Korea (683.72 billion Korean Won [US$613.98 million] of which 110% was Pharmaceuticals).

Sales Analysis. Luye Pharma Group Limited reported sales of 777.88 million Singapore Dollars (US$569.05 million) for the year ending December of 2017. This represents an increase of 28.4% versus 2016, when the company's sales were 605.73 million Singapore Dollars. Sales of Alimentary Tract and Metabolism Drugs saw an increase of 32.7% in 2017, from 115.11 million Singapore Dollars to 152.78 million Singapore Dollars. Not all segments of Luye Pharma Group Limited experienced an increase in sales in 2017: sales of Other fell 4.7% to 27.98 million Singapore Dollars. (However, this segment's sales were only a very small portion of the company's overall sales). Luye Pharma Group Limited also experienced decreases in sales in Cardio-Vascular System Drugs (down 3.0% to 131.32 million Singapore Dollars) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Luye Pharma Group Limited
  Stock Performance Chart for Luye Pharma Group Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): .98
(Figures in Singapore Dollars)
1 Week -10.3%   13 Weeks -8.5%  
4 Weeks -18.5%   52 Weeks 14.4%  
 
Luye Pharma Group Limited Key Data:
  Ticker: 2186 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 777,884,432
(Year Ending Jan 2018).
Employees: 3,921
  Currency: Singapore Dollars Market Cap: 3,212,708,252
  Fiscal Yr Ends: December Shares Outstanding: 3,274,965,343
  Share Type: Ordinary Closely Held Shares: 1,602,675,625
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.